Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Newsletter 2020

European Journal of Anaesthesiology highlights

From the deputy editor:

With this article, we open up a new rubric for all members of our Society who are thirsty for new and exciting research published in the European Journal of Anaesthesiology. It is another good example of collaborative work between different groups of ESAIC with the sole objective of helping the clinicians answering day to day clinical dilemmas or unknowns.

Marc Gimenez

We strongly recommend the prospective cohort study by Wang et al (1) studying the incidence and risk factors of delirium (POD) on patients admitted in ICU after intracranial surgery. Although there are abundant studies on POD, there are only small retrospective series dedicated to patients undergoing neurosurgical procedures. The authors found not only that one-fifth of patients were diagnosed with postoperative delirium, but also new risk factors such as frontal approach craniotomy and the nature of the intracranial lesion.

On similar lines, we reflect on the findings of the systematic review and meta-analysis by Pereira et al (2)comparing propofol with dexmedetomidine in reducing POD in ICU. Six randomised controlled trials (RCT) and two retrospective studies seemed to show that dexmedetomidine protected against POD compared with propofol (RR 0.70 95% CI 0.52-0.95 p=0.02). Also, no differences were found with side effects, time of mechanical ventilation or hospital and ICU length of stay.

Staying with ICU, Taboada et al. (3) propose a prospective observational study on reintubation in the ICU after cardiac surgery. The authors report a higher difficulty with laryngoscopy and incidence of relevant haemodynamic and respiratory complications during reintubation in ICU as compared with intubations in the operating theatre. Findings that may help with respiratory weaning protocols and workload schedules in cardiac ICUs.

The last study we would like to bring to your attention is the RCT performed by Zhang et al (4) that could help us providing safer anaesthesia to paediatric patients with recent upper respiratory tract infection having interventional cardiac surgery. 134 children were allocated to receive intranasal dexmedetomidine or placebo (saline) before induction of anaesthesia and pre-defined respiratory incidents were studied. Administration of dexmedetomidine seemed to reduce the appearance of respiratory events such as bronchospasm, laryngospasm and desaturation in children less than three years.


1. Wang, Chun-Mei; Huang, Hua-Wei; Wang, Yu-Mei; et al. Eur J Anaesthesiol 2020; 37:14-24.
2. Pereira, Jarett V.; Sanjanwala, Rohan M.; Mohammed, Mohammed K.; et al.. Eur J Anaesthesiol 2020 ;37:121-131
3. Taboada, Manuel; Rey, Raúl; Martínez, Susana; et al. Eur J Anaesthesiol 2020;37:25-30
4. Zhang S, Zhang R, Cai M, et al.. Eur J Anaesthesiol 2020;37:85-90